What happened in the stock market today

Woodford Equity Fund calls it a day, while Woodford Patient Capital (LON: WPCT) loses big.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Trading in the major market indices has been subdued today, with the FTSE 100 down just a quarter of one percent as I write, and the FTSE 250 up half a percentage point. However, the pound reached a five-month high against the euro on comments from lead EU Brexit negotiator Michel Barnier that a deal is possible. 

Regardless, today is likely to be the deadline for any deal, as it would need to be ratified by EU leaders at Wednesday’s summit. If it does not agree to the deal, it will consider an extension. In the event that a Brexit deal is not reached, Saturday will then become the new deadline for Parliament to decide whether to ask for an extension to Article 50.

Woodford Equity Fund

The time is finally up for Neil Woodford’s Equity Income Fund. Today, the decision was made to not re-open the fund for trading, and instead to appoint an external asset manager to conduct an orderly sale of its holdings. 

The fund was suspended back in June, when mounting levels of redemptions caused a liquidity crisis, locking in investors in an attempt to allow Woodford to generate some much-needed cash. Woodford had a large number of illiquid assets on its books, which made it difficult to return capital to investors when they started losing confidence in his management. Ironically, it was the previous wave of redemptions that forced Woodford to sell many of his large-caps, thereby making illiquid assets a much larger proportion of his overall portfolio.

What does this mean for investors in the fund? Unfortunately, they will have to wait until at least January to get their money back. The liquidation process has to be drawn out to ensure that Woodford’s assets are sold at reasonable prices, which ultimately should ensure that investors will get as much of their capital back as possible. Still, this is hardly the news that they would have wanted to hear.

Unsurprisingly, Neil Woodford himself believes that his firing and the liquidation of his fund is a mistake, stating: “This was Link’s [the appointed corporate director’s] decision and one I cannot accept, nor believe is in the long-term interests of LF Woodford Equity Income Fund investors”.

Meanwhile, questions continue to percolate about the future of his other investment vehicle, Woodford Patient Capital (LSE: WPCT), shares of which are down almost 9% today. Although it is a separate entity to the Equity Income Fund, investors are now questioning its governance and management’s decision-making, fearing that the same problems could rear their ugly heads again. There is speculation that Neil Woodford could be replaced as head of Patient Capital, and that it may cease to exist altogether. 

Perhaps the lesson to be learned from this is that internal governance can be weak in funds headed by celebrity investment managers. As with stocks, it is often advisable to invest in relatively unknown entities. Or better yet, get a Stocks and Shares ISA and take control of your retirement savings. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Stepan Lavrouk owns no shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

The AstraZeneca share price lifts 5% on a top-and-bottom earnings beat

The AstraZeneca share price reached £120 today and helped push the FTSE 100 higher. Would I still buy this flying…

Read more »

Young black woman using a mobile phone in a transport facility
Market Movers

Meta stock slumps 13% after poor results. Here’s what I’ll do

Jon Smith flags up the reasons behind the fall in the Meta stock price overnight, along with his take on…

Read more »

Young Caucasian girl showing and pointing up with fingers number three against yellow background
Investing Articles

3 FTSE stocks I wouldn’t ‘Sell in May’

If the strategy had any merit in the past, I see no compelling evidence it's a smart idea today. Here…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

Down 21% and yielding 10%, is this income stock a top contrarian buy now?

Despite its falling share price, this Fool reckons he's found an income stock that could be worth taking a closer…

Read more »

Investing Articles

The Meta share price falls 10% on weak Q2 guidance — should investors consider buying?

The Meta Platforms' share price is down 10% after the company reported Q1 earnings per share growth of 117%. Does…

Read more »

Investing Articles

This FTSE 250 defence stock looks like a hidden growth gem to me

With countries hiking defence spending as the world grows more insecure, this FTSE 250 firm has seen surging orders and…

Read more »